AFM
SONM icon

Anson Funds Management’s DNA X Inc SONM Stock Holding History

Anson Funds Management’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-74
Closed -$97K – 298
2020
Q4 		$97K Buy
+74
New +$80.8K 0.02% 163
2020
Q1 		– Sell
-38
Closed -$249K – 98
2019
Q4 		$249K Buy
+38
New +$187K 0.29% 69

Other funds holding SONM

BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
USPCM
Union Square Park Capital Management New York $176M AUM 51.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Anson Funds Management's SONM Position: Q1 2021 in Review

Anson Funds Management sold out of DNA X Inc (SONM) in Q1 2021, closing a stake of 74 shares — an estimated $97K sold.

Anson Funds Management first reported a position in SONM in Q4 2019 and held it in 2 quarters. The position peaked at $249K in Q4 2019. 23 funds tracked by Wall St. Rank hold SONM as of Q1 2021.

  • Anson Funds Management reported no remaining DNA X Inc position as of Q1 2021 after selling out during the quarter.
  • Anson Funds Management sold 74 DNA X Inc shares in Q1 2021, an estimated $97K.
  • Anson Funds Management first reported a position in DNA X Inc in Q4 2019 and held it in 2 quarters.
  • Anson Funds Management's DNA X Inc position peaked at $249K in Q4 2019.
  • 23 funds tracked by Wall St. Rank held DNA X Inc as of Q1 2021.

Based on Anson Funds Management's 13F filing for Q1 2021, filed 14 May 2021.